The second-generation air-Q ® intubating laryngeal airway is a newer commercially available supraglottic airway device. In this retrospective review, we describe our initial clinical experience of 70 insertions. The ease and number of insertion attempts, airway leak pressure, device positioning, duration of use, success of fibreoptic-aided intubation and oropharyngeal morbidity were recorded.
The air-Q ® intubating laryngeal airway (ILA, Mercury Medical, Clearwater, FL, USA) is a newer commercially available supraglottic airway (SGA) marketed for use as a primary airway during maintenance of anaesthesia. Additional design features, which include a pre-curved short airway tube with an internal diameter (ID) large enough to allow direct passage of tracheal tubes up to 8.5 mm ID, are reported by the device manufacturer to facilitate blind and fibreoptic-aided tracheal intubation using the mask as a conduit. After its initial introduction, post-marketing clinical experience indicated that air leaks were occurring between the posterior 'heel' of the cuff and the base of the tongue limiting the maximum pharyngeal seal pressure that could be attained. In response, this area of the mask was enlarged. Additionally, the singleuse device incorporated a softer, more compliant polyvinylchloride (PVC)-based material into the cuff (personal communication, Dr Dan Cook, inventor of the ILA). This newer ILA became available in early 2009.
In the current financial climate, decisions are often made at the institutional or departmental levels to use a device based on cost considerations with or without an appropriate 'trial' of the device in actual clinical settings. These 'trials' typically involve the device manufacturer or distributor supplying a number of devices free of charge, which are then essayed by anaesthesia providers on patients. The number of uses per anaesthesiologist is typically small and therefore any resulting beliefs about the utility of the device compared to whatever is potentially being replaced is solely based on opinion and not necessarily supported by data. Since little information is available regarding the use of the ILA in general or the second generation device in particular, we aimed to describe our initial experience with attention given to the duration, ease and number of attempts at insertion, airway leak pressure (ALP), supraglottic positioning, oropharyngeal morbidity and its utility as an intubating conduit.
METHODS
Between 1 April and 31 July 2009, we considered introducing use of the ILA into clinical practice at the University of Wisconsin Hospital and Clinics. Before starting a planned device trial, we devised a structured data collection form consisting of information available during routine anaesthetic care that we believed would be pertinent for assessing the usefulness of any commercially available SGA before widespread clinical introduction. Because data were collected anonymously (containing no private health information) during routine standard care, the University of Wisconsin Minimal Risk-Institutional Review Board (Madison, WI, USA) approved this report with a waiver of informed consent, specifically under exemption category 45 CFR 46.101(b)(4): "Research involving the collection or study of existing data, documents, records, pathological specimens, or diagnostic specimens, if these sources are publicly available or if the information is recorded by the investigator in such a manner that subjects cannot be identified, directly or through identifiers linked to the subjects".
In order to ensure that each participating provider would have sufficient experience using the ILA to shape a reasonable purchasing opinion, we decided to limit the number of anaesthesia providers with access to the ILA. Insofar as the LMA-Classic™ (LMA North America, San Diego, CA, USA) is recognised to have a short-term learning curve of 15 insertions 1 , we believed that each participating provider should place a minimum of 20 ILA devices. Based on the quantity of single-use and reusable device samples supplied by the manufacturer, we limited the number of participating 'trialists' to four.
Patient selection
The ILA was used in patients 1) in whom a SGA was chosen as the appropriate primary airway device, 2) as a conduit for fibreoptic-aided tracheal intubation in known or unanticipated difficult airways or 3) as a conduit for intubation to be left in place (deflated) with the tracheal tube through it, obviating the need for a Bailey manoeuvre 2 at the end of the case.
Routine anaesthetic care
Patients undergoing surgical procedures were premedicated with midazolam 2 mg intravenously just prior to leaving the holding area. Upon arrival in the operating room, standard monitors were applied and patients were pre-oxygenated with high fresh gas flow during normal tidal breathing for approximately three minutes. Anaesthesia was induced intravenously using propofol 2 to 3 mg/kg with or without fentanyl 1 to 2 µg/kg administered two to three minutes prior to induction. After the loss of eyelash reflex, the patient was mask ventilated for approximately 30 seconds with 4 to 6% sevoflourane in 8 l/minute of 100% oxygen until the patient was unresponsive to a jaw thrust. The manufacturer's weight-based size recommendations were not followed. Size 3.5 and 4.5 ILAs were placed in all women and men, respectively. Devices were not placed using the traditional digital insertion technique with the bowl fully deflated as is recommended for the LMA-Classic. Rather, just enough air was withdrawn from the device to cause visible dimpling in the posterior portion of the cuff. The ILA was then placed into the mouth behind the tongue and the index finger of the operator's left hand was used to guide the tip of the cuff around the base of the tongue. Simultaneously, a caudad force was applied with the operator's right hand on the airway tube and the device rotated into position. This technique is believed to lead to greater first attempt insertion success while minimising trauma to the posterior pharynx (personal communication, Dr Dan Cook). The cuff was then inflated with air until the pilot balloon of the device was bouncy, but not firm. Pressure manometer-guided cuff inflation was not used as the manufacturer only makes a recommendation for maximum cuff inflation volume.
Data collection
Insertion time was measured using a digital stopwatch mounted on the anaesthesia workstation as the time from picking up the ILA to the presence of an end-tidal carbon dioxide tracing on the anaesthesia monitor. The stopwatch was located just above the anaesthesia breathing circuit so that the anaesthesia provider could easily press the start and stop buttons when picking up the ILA and just after manually ventilating the patient, respectively. ALP was measured after establishing ventilation by Anaesthesia and Intensive Care, Vol. 39, No. 1, January 2011 fully closing the airway pressure release valve on the anaesthesia machine while delivering a continuous gas flow of 5 l/minute. ALP was recorded when there was an audible air leak or a maximum pressure of 40 cmH 2 O was reached. The stomach was then auscultated and gastric insufflation, if present, was noted. For patients in whom a SGA was planned as their primary airway device during maintenance of anaesthesia, device failure was defined clinically as an inadequate seal to achieve sufficient positive pressure for adequate ventilation. The decision on whether or not to remove the ILA was based solely on the provider's clinical judgement. All surgical patients received some form of positive-pressure ventilation during surgery using either pressurecontrol (PCV) or pressure-support (PSV) ventilation with the SmartVent 7900 of the Aestiva/5 anaesthesia workstation (Datex-Ohmeda, GE Healthcare, Waukesha, WI, USA). Inspiratory airway pressures were titrated to achieve tidal volumes >5 ml/kg up to a total peak airway pressure (inspiratory plus positive end-expiratory pressure) of approximately 5 cmH 2 O less than the initial ALP. When PCV was used, both peak airway pressure and respiratory rate were titrated to maintain end-tidal carbon dioxide tension (CO 2 ) <45 mmHg. Anaesthesia was maintained with inhaled desflurane or sevoflurane in combination with intravenous opioids. Insofar as the device manufacturer states that the ILA is suitable for blind or fibreoptic-aided tracheal intubation, we decided to assess the relationship of the bowl of the mask to the laryngeal inlet whenever clinically indicated (e.g. questionable positioning or planned intubation). In these settings, the fibreoptic bronchoscope was placed to the end of the airway tube and its position graded as: 1=full view of the vocal cords, 2=partial view of the cords including arytenoids, 3=epiglottis only or 4=other (laryngeal mask airway, cuff, pharynx, other).
Where intubation was desired, a non-depolarising neuromuscular blocking drug was administered and intubation proceeded using direct fibreoptic guidance. Blind intubation was not attempted. Specifically, after the ILA was placed, ventilation confirmed and ALP tested, the ILA circuit adapter was removed and a tracheal tube of 7 to 8 mm ID was inserted in the ILA airway tube to a depth of 18 cm. A fibreoptic endoscope (Pentax fiberscope FB-15V or FB-18V, 4.9 mm or 6 mm outer diameter, Pentax Medical Company, Montvale, NJ, USA) was inserted through the tube and into the trachea. The tracheal tube was then railroaded over the scope. If any resistance was encountered, the tube was rotated by 90° increments during advancement.
After confirming ventilation through the tracheal tube, the ILA was deflated and removed using a size #1 ILA Removal Stylet (Mercury Medical, Clearwater, FL, USA) if use of the ILA for emergence was not planned. Intubation success or failure was recorded. Any adverse events were noted. The same procedure was followed when the ILA was used for out-of-operating room airway management, except non-depolarising neuromuscular blocking drugs were not administered until ventilation was confirmed with the ILA.
At the conclusion of the surgical anaesthetic, among patients who were not intubated, the ILA was removed when the patient was breathing spontaneously and able to follow simple commands. Presence of blood streaking, bile or gastric contents on the device after removal was noted. Prior to discharge from the postoperative recovery area, patients were questioned about presence of a sore throat. If present, patients were asked to rate it as mild, moderate or severe. In addition, a cursory oropharyngeal examination was performed and the presence of any oropharyngeal blood or soft tissue injury was noted. No follow-up outside of routine care was performed.
Data were analysed using Prism 5.0a (GraphPad Software, Inc., La Jolla, CA, USA). ALP between single-use and reusable devices was compared using a t-test with significance defined as a two-sided P value <0.05. Data are presented as number (%), mean (SD) or median (interquartile range [range]) unless otherwise noted.
RESULTS
Patient characteristics and the type of surgical procedures for which ILAs were used are presented in Table 1 . Device and usage characteristics are presented in Table 2 . Of the 37 single-use devices placed, 13 (35%) and 24 (65%) were size 3.5 and 4.5 respectively. Of the 33 reusable devices placed, 19 (58%) and 14 (42%) were size 3.5 and 4.5 respectively. With the reusable device, 75% had an ALP >26 cmH 2 O and none provided an ALP <20 cmH 2 O. As the primary airway during maintenance of anaesthesia, the ILA performed adequately in all 57 (100%) patients in which it was used.
In 20 patients, a fibreoptic bronchoscope was used to confirm placement of the ILA and/or to aid in tracheal intubation. In these cases, grade 1/2/3/4 views were observed in 18/0/2/0 of cases. Tracheal intubation through the ILA was successful in 12 of 13 (92%) attempts (10 in-operating room, 3 out-of-operating room). In the one case of failed intubation, the ILA was easily inserted and had an ALP >20 cmH 2 O, but the vocal cords could not be visualised. Preoperative airway examination in this case was reassuring for easy direct laryngoscopy, so the ILA was removed and the patient was intubated without complications. Overall, intubation was noted to be easy, slightly difficult, difficult and impossible in 10 (77%), 2 (15%), 0 (0%) and 1 (8%) instances respectively.
In two patients, one undergoing cranioplasty and one undergoing kidney transplant, the ILA was deflated after successful intubation and left in place for the duration of the surgery. Once the patient had resumed spontaneous ventilation at the conclusion of the procedure, the ILA was reinflated and the tracheal tube was removed. The patient was then allowed to emerge from anaesthesia using the ILA. No anaesthetic complications were encountered in either patient, and neither patient complained of a sore throat in the recovery area.
In three patients, the ILA was used for airway management in the intensive care unit for both anticipated and unanticipated difficult intubation. One of these patients had suffered a cervical spine fracture and was in a rigid collar. Adequate mouthopening was achieved to allow placement of a fully deflated ILA, so the cervical collar was left in place during successful intubation. In all three patients, ventilation was adequate with PCV via the intensive care unit ventilator and a full view of the vocal cords (grade 1) was present. The tube was passed easily in all three patients.
Airway morbidity is summarised in Table 3 only for those in whom the ILA was used as the primary airway during anaesthesia. In one patient where the ILA was left in place deflated for the case after using it as an intubating conduit, a small amount of gastric contents was noted on the ILA upon removal. No clinical signs of aspiration were evident on examination. The patient denied soreness of throat and was discharged home from the ambulatory surgery recovery area within two hours after the operation. The presence or absence of blood and/or gastric contents on the device at removal was not recorded in two patients. No gastric insufflation was noted after insertion and there were no clinically evident intraoperative aspirations.
DISCUSSION
Our main findings are that the second-generation ILA performed adequately as a primary airway during maintenance of anaesthesia with and without mechanical positive pressure ventilation. This was true for single-use and reusable versions. In addition, as a conduit for fibreoptic-aided tracheal intubation, the ILA provided adequate views of the glottic opening to facilitate intubation in 92% of patients. The numbers of insertion attempts, ease of insertion and time for insertion were similar to those reported for other SGAs [3] [4] [5] [6] [7] [8] [9] [10] . More specifically, the insertion time (22±14 seconds) and successful insertion rate in two attempts or fewer (100%) was almost identical to that reported in a recent prospective pilot study of the ILA in 59 patients (26±13 seconds and 96.5%, respectively) 11 . In contrast, the ALP we report is higher. Potential explanations for this discrepancy are that we inserted an ILA of newer cuff design made with a softer, more compliant material and that silicone-based reusable devices were used in nearly half of our patients. Differences between PVC-and siliconebased devices have been previously reported. Although originally postulated to be less conforming to the surrounding pharyngeal anatomy resulting in a lower ALP, PVC-based single-use airways have been reported to provide similar quality of airway maintenance to the identical reusable version 12 .
Thus the significantly higher ALP displayed by the reusable device in our series is interesting as it suggests that while identical design geometry may make both versions equally effective as a conduit for intubation, the reusable device may be preferable for airway maintenance. Nonetheless, the ALP we report for the single-use ILA is comparable to other newer generation single-use SGAs such as the LMA-Supreme™ (LMA North America, San Diego, CA, USA) and the iGel (Intersurgical, Liverpool, NY, USA), while the ALP provided by the reusable ILA is more of the order of the LMA-ProSeal™ (LMA North America, San Diego, CA, USA) [3] [4] [5] [6] [7] [8] [9] [10] 13 .
With regard to using the ILA as a conduit for intubation, blind passage of the tracheal tube has been reported to be successful within three attempts in 60% 14 and 74% 11 , respectively. In a simulation model, time to completion improved by 34% after only five attempts with success rates of over 90% 15 .
Between these two studies, one in abstract form only and the other in a peer-reviewed journal, a total of 100 patients, 40 in one and 60 in the other, are described. Insofar as we were collecting quality data, we did not believe that utilising a blind intubation technique, when direct fibreoptic bronchoscopeaided visualisation was possible, was within our local standard of care. Thus, we only describe the success of fibreoptic-aided intubation. We obtained adequate exposure of the vocal cords to allow intubation with less than or equal to slight resistance to passage of the tracheal tube in 12/13 (92%) patients, which compares favourably with a previous report of a 94% success rate in 16 patients who could not be blindly intubated through the ILA 11 . In our series, intubation was successful in all cases in which any part of the vocal cords could be visualised.
The majority of our patients had no throat complaints. The presence of macroscopic blood was similar in our series (16%) to that of Bakker et al (17%) 11 . However, more of our patients complained of a sore throat, although the majority of these complaints were mild and had completely resolved prior to discharge. One patient had moderate pain that persisted after discharge. No patient exhibited severe pain. We could postulate that the lack of manometry-guided ILA cuff inflation might have led to higher intracuff pressures and the resultant prevalence of pharyngeal complaints. Recently, a double-blind randomised trial comparing pharyngolaryngeal complications in patients managed with manometers to limit the laryngeal mask airway intra-cuff pressure (<44 mmHg) with patients undergoing routine care reported that using manometry routinely reduced complications from 45.6 to 13.4%; a relative risk reduction of 70% 16 . However, in a study of the LMA-Classic, cuff inflation volume, intracuff pressure, ALP and the pressure exerted upon the pharyngeal mucosa at several contact points did not correlate and pharyngeal mucosal pressures were generally lower than those considered safe for the tracheal mucosa during prolonged intubation 17 . Therefore it is difficult to say whether the postoperative throat complaints we report is inherent to the design of the ILA itself or how it was used in our series.
The second-generation ILA is a newer product in the continual evolution of the supraglottic airways. In our experience, the device was easily inserted and functioned adequately for airway maintenance during anaesthesia. In addition, as a conduit for intubation, the ILA provided adequate fibreoptic
